ArticleHeliyon2024
A retrospective study investigating semen parameter profiles among male patients attending a fertility center in the UAE: Insights from a nationality perspective.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Temporal trends in semen parameters among men attending a fertility center in the UAE (2012 - 2022): a retrospective study.Frontiers in physiology · 2026Article
- Prevalence of chromosomal abnormalities and polymorphisms in 4,672 infertile patients undergoing assisted reproductive techniques in the United Arab Emirates population.Frontiers in reproductive health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The current study assessed the epidemiological trends of semen phenotypes and their association with ethnicity among men seeking fertility treatment in the United Arab Emirates (UAE). Methods: This retrospective study assessed the anthropometric information including age, body mass index (BMI), and nationality, along with semen parameters of men who visited a Fertility Center in Abu Dhabi, UAE between January 2011 and July 2022. To understand the epidemiological trend of semen parameters amongst UAE nationals, propensity score analysis and logistic regression were performed. Thus, the exposure variable of interest is ethnicity, categorized into UAE nationals (Emirati) and Others (minus UAE; Global). Statistical analysis was performed using SPSS, R packages and STATA. Results: In this study, 32,664 samples were collected from 19,482 patients from 113 countries worldwide over a period of 11 years. Most participants made multiple visits, with around 40 % attending at least once. Following covariates adjustment, logistic regression indicated a non-significant increase (4 %) in the prevalence of asthenozoospermia among the UAE population compared to Global. Further modeling adjusted for propensity score and Emirati status suggested that Emiratis were 13 % less likely to have lower total sperm count (TSC) compared to Global (p < 0.001). Whereas approximately 58 % of UAE nationals' samples exhibited teratozoospermia compared to 56 % in other nationalities. After adjusting for confounders, analysis revealed a significantly higher prevalence (12 %) of teratozoospermia among Emiratis compared to other nationals. Conclusion: Samples from UAE nationals displayed reduced sperm motility and normal morphology but increased TSC. While the underlying cause of these observed phenotypes was not investigated, it is worth noting that all the men including those from other nationalities resided in the UAE and were subjected to the same climate. Thus, other factors, such as ethnicity, may have primarily influenced the differences observed in these parameters, with genetic makeup also potentially contributing to these outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.